HIV Trial Modified Factorial Design Best For Study In Treated Patients - Cmte.
Executive Summary
Modified factorial trial designs are the best strategy for studying new therapies in heavily treated HIV patients, FDA's Antiviral Drugs Advisory Committee suggested.
You may also be interested in...
HIV Trials Should Focus On Pre-Treated Patients, FDA Guidance Says
FDA is encouraging sponsors of HIV therapies to conduct more clinical trials in treatment-experienced patients
HIV Trials Should Focus On Pre-Treated Patients, FDA Guidance Says
FDA is encouraging sponsors of HIV therapies to conduct more clinical trials in treatment-experienced patients
HIV "Salvage" Drug Efficacy May Be Shown With Half-Log Drop In Viral Load
A .5-log drop in viral load may be an optimal endpoint for testing "salvage" therapies in treatment-experienced HIV patients, FDA's Antiviral Drugs Advisory Committee concluded.